170 related articles for article (PubMed ID: 22450712)
1. E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma.
Palaiologou M; Koskinas J; Karanikolas M; Fatourou E; Tiniakos DG
Virchows Arch; 2012 May; 460(5):439-46. PubMed ID: 22450712
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
[TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
4. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
9. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin.
Peroukides S; Bravou V; Alexopoulos A; Varakis J; Kalofonos H; Papadaki H
Histol Histopathol; 2010 Mar; 25(3):299-307. PubMed ID: 20054802
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
12. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.
Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA
World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214
[TBL] [Abstract][Full Text] [Related]
14. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
[TBL] [Abstract][Full Text] [Related]
15. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Insulin-Like Growth Factor-1 Receptor and Its Association with Clinicopathological Parameters in Hepatocellular Carcinoma.
Peloso Maia ML; Albuquerque RM; do Carmo Silva SD; Lima CX; Costa Diniz PH; Vieira Teixeira Vidigal P
Oncology; 2024; 102(6):494-502. PubMed ID: 37989120
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
18. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
20. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.
Chang L; Xi L; Liu Y; Liu R; Wu Z; Jian Z
Mol Med Rep; 2018 Jan; 17(1):342-349. PubMed ID: 29115436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
